INTRODUCTION
Eucaryotic cells contain a number of distinct compartments characterized largely by the unique set of proteins residing within them. This high degree of organization requires specific mechanisms to sort and deliver proteins from their site of synthesis in the cytoplasm to their final intracellular or extracellular destination. The pathway for proteins destined for the lysosomal/vacuolar compartment of eukaryotic cells represents a wellstudied example of an intracellular protein sorting pathway (Kornfeld and Mellman, 1989; brane of the endoplasmic reticulum and then are transported to the Golgi complex. Within the Golgi apparatus, the pathways diverge. Secretory protein traffic proceeds by a bulk flow, or default mechanism, to the cell surface, whereas lysosomal proteins contain additional sorting information that directs their delivery to the lysosome (Kornfeld, 1986; Kornfeld and Mellman, 1989) .
In a variety of mammalian cells, the N-linked carbohydrate side chains on soluble lysosomal proteins are modified with mannose-6-phosphate residues that are recognized by specific membrane receptors that mediate lysosomal delivery (Kaplan et al., 1977; Kornfeld and Mellman, 1989) . The targeting signals on soluble proteins destined for the lysosome-like vacuole in the yeast Saccharomyces cerevisiae are not comprised of specific carbohydrate modifications but instead appear to reside directly within the polypeptide backbone of these proteins (Clark et al., 1982; Schwaiger et al., 1982; Johnson et al., 1987; Valls et al., 1987; Klionsky et al., 1988 MATa/MATa leu2-3,112/leu2-3,112 his3-A200/his3-A\200 ura3-52/ura3-52 trpl-A901/rpl-A901 suc2-A9/suc2-A9 ADE2/ade2-101 lys2-801/ LYS2 SEY35-17 SEY6210 vps35-17 Robinson et al., 1988 GPY1 135 SEY6211 vps35MI::HIS3 This study
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MATa leu2-3,112 ura3-52 his3-A200 trpl-A901 ade2-101 suc2-A9 pep4MI::LEU2 In an attempt to identify cellular components required for vacuolar protein sorting in S. cerevisiae, several genetic selection procedures have been employed. Each has resulted in the isolation of mutants that exhibit defects in vacuolar protein processing and/or localization (Jones, 1977; Bankaitis et al., 1986; Robinson et al., 1988; Rothman et al., 1989) .
These vacuolar protein sorting (vps) mutants missort vacuolar enzyme precursors to the cell surface. Together, these mutants define more than 45 complementation groups. In addition to the observed sorting defects, analysis of vacuolar morphology by light and electron microscopy has revealed that several of the vps mutants possess abnormal vacuolar structures . Based on these morphological studies, the vps mutants were assigned to three distinct classes. The majority of the mutants (called class A vps mutants) contains normal or slightly enlarged vacuole structures. A second class of mutants, class B, is characterized by the presence of multiple small vacuole-like organelles. Finally, class C mutants lack any compartment that resembles a wildtype vacuole.
Thirty-two mutant alleles of the VPS35 locus were originally isolated using a gene fusion-based selection scheme for mutants that missort and secrete a carboxypeptidase Y-invertase (CPY-Inv) hybrid protein. vps35 mutant cells also exhibited defects in the sorting of the authentic soluble vacuolar hydrolase carboxypeptidase Y (CPY) . Light and electron microscopic analysis revealed that vps35 mutant cells contain morphologically normal vacuoles (class A) . This indicates that vps35 cells are competent for vacuole assembly and suggests that the VPS35 gene product may be involved in the sorting of only a subset of vacuolar enzymes.
In an effort to better understand the role of the VPS35 gene product in vacuolar protein sorting and delivery, we report here on the cloning and sequencing of the VPS35 gene, the phenotypic consequences of a vps35 null allele, and the identification and localization of the VPS35 gene product. We describe a simple plate assay technique that we devised for cloning the VPS35 gene. This technique should prove generally useful for the cloning of many other genes that affect the sorting or retention of proteins in the secretory pathway. Based on our findings, we suggest that the Vps35 protein (Vps35p) is a component of a membrane associated multiprotein complex that is required for the sorting of only a subset of vacuolar proteins.
MATERIALS AND METHODS Strains and Media
The S. cerevisiae and Escherichia coli strains used are listed in Table  1 . Bacterial strains were grown on standard media (Miller, 1972) . Yeast strains were grown on yeast extract, peptone, dextrose (YPD) medium, on synthetic medium (SM) supplemented as necessary (Sherman et al., 1979) , or on Wickerham's minimal proline medium (WiMP) (Wickerham, 1946) GIBCO (Grand Island, NY) . All other chemicals including antiserum to glucose-6-phosphate dehydrogenase were from Sigma Chemical (St. Louis, MO). Antibodies to Kex2p were a gift from Kyle Cunningham, and the antisera to CPY, proteinase A (PrA), and alkaline phosphatase (ALP) were described previously Klionsky and Emr, 1989) . The antisera to protease B (PrB) was a generous gift from Elizabeth Jones, Carnegie-Mellon University, Pittsburgh, PA.
Yeast Genetics and Transformation
Genetic crosses, sporulation of diploids, and dissection of tetrads were performed as previously described (Sherman et al., 1979) . Yeast transformations were performed by the method of Ito et al. (1983) .
Typically, 1 ,tg of plasmid DNA was added to 100 ml of competent cells. For integrative transformations, 200 ng of linear DNA fragment were used together with 10 Ag of circular pBluescript plasmid (Stratagene, La Jolla, CA) as carrier DNA. For gene disruption, the 2.7-kb Nci I/Xba I fragment from pGPY55 (see below) was transformed into the diploid strain SEY6210.5. His' transformants were sporulated and the resultant asci dissected. Integrative mapping strains were constructed as follows. pVPS35-10 (see below) was linearized with Asp718I and used to transform BHY11 to Trp+, yielding BHY158.
BHY158 was crossed with BHY157, diploids were selected, sporulated, and the resultant asci dissected.
Cloning of VPS35 With an Invertase Plate Assay 112 ) carrying a plasmid encoding the CPY-Inv fusion protein (pCYI-50) (Johnson et al., 1987) were transformed with a yeast genomic library contained in a pBR322-based LEU2/CEN4/ARS1 shuttle vector (a generous gift from Philip Hieter, Johns Hopkins University School of Medicine, Baltimore, MD), and Leu+ transformants were selected. Leu+ colonies were replica plated onto selective SM fructose medium and incubated overnight at 26°C.
An invertase assay solution containing 125 mM sucrose, 100 mM sodium acetate (pH 5.5), 10 ig/ml horseradish peroxidase, 8 units/ ml glucose oxidase, 2 mM 0-dianisidine Uohnson et al., 1987; Klionsky et al., 1988) was mixed with an equal volume of a 2.4% agar solution (at 50°C) and immediately poured over the replica colonies. After 5 min at room temperature, colonies secreting the CPY-Inv fusion protein turned red (indicating Vps-phenotype), and colonies with internal invertase activity remained white (Vps+). Plasmids conferring the Vps+ phenotype were isolated from these yeast cells as described previously (Braus et al., 1985) .
Vectors and Plasmid Constructions
E. coli plasmids pBluescript KS(+) and (-) were obtained from Stratagene. The E. coli-yeast shuttle vector pPHYC16 has been described by and the 2,u plasmid pBHY10 by Horazdovsky, and Emr, (unpublished data). The HIS3 gene was isolated from a plasmid kindly provided by E. Phizicky, Dept. of Biochemistry, University of Rochester, Rochester, NY. The pATH1 vector used in constructing the trpE-Vps35 fusion protein has been described elsewhere (Dieckmann and Tzagoloff, 1985) . A 5.8-kb Sph I-Xba I complementing fragment from the originally isolated vps35 complementing plasmid was subcloned into pPHYC16 to generate pGPY35. Plasmid pGPY45 was constructed by excising the 3.8-kb Nci I/Sca I fragment from pGPY35, filling in the Sca I site with Klenow and ligating the complementing fragment into the Sma I site of pBHY10. The integrative mapping plasmid, pVPS35-10, was constructed by inserting the Nci I/Sca I VPS35-containing fragment into the integrative mapping vector pPHY110 
Northern Blot Analysis
For Northern blot analysis, yeast RNA was prepared as previously described (Zitomer and Hall, 1976) and enriched for poly(A)+ RNA according to Aviv and Leder (Aviv and Leder, 1972) . RNA was separated on a formaldehyde-agarose gel as in Rave et al. (1979) , transferred to GeneScreen membranes, and hybridizations were as described in Thomas (1980 (Pearson and Lipman, 1988) of the University of Wisconsin Genetics Computer Group sequence analysis package (Devereux et al., 1984) .
Preparation of Vps35p Specific Antisera
A gene fusion between the E. coli trpE gene and VPS35 was constructed by subcloning a 0.5-kb EcoRV/Cla I fragment encoding amino acids 630-808 of Vps35p into Sma I/Cla I digested pATH1 (Dieckmann and Tzagoloff, 1985) , generating an in-frame fusion gene. The fusion point was sequenced to ensure correct in-frame fusion. This trpEVps35 fusion protein was induced and prepared as previously described by Kleid et al. (1981) with the following modifications: induction was overnight, cells were broken in a freeze-thaw step, and 2% Triton X-100 was used instead of Nonidet P-40 , cells were grown in WiMP as above. Zymolyase 100T 10 ,ig/2 X 107 cells Vol. 3, April 1992 were added, and the culture was incubated 30 min at 30°C. Spheroplasts were washed in 1.2 M sorbitol and labeled as described above in WiMP, 1.2 M sorbitol. The immunoprecipitations were as described , except that three washes were performed: once with buffer A (50 mM tris(hydroxymethyl)aminomethane [Tris]-HCl, pH 7.5, 150 mM NaCl, 0.1 mM EDTA) containing 0.5% Triton X-100, once with buffer A plus 2 M urea, and then again with buffer A. Samples were separated in 10% SDS-polyacrylamide gels as previously described (Laemmli, 1970) . Subcellular Fractionation SEY6210 (wild-type) cells were spheroplasted and labeled 5 min as described above. The cultures were chased with cold methionine (10 mM) for 5 min, and the chase was stopped by diluting the labeled culture in one volume of ice-cold WiMP and incubating it on ice for 5 min. The spheroplasts were sedimented 3 min at 500 X g, resuspended in 2 ml of lysis buffer (10 mM triethanolamine, pH 7.2, 0.8 M sorbitol, 1 mM EDTA) containing a protease inhibitor cocktail (1 mM phenylmethylsulfonylfluoride [PMSF], 50 ,g/ml leupeptin, 50 ,ug/ml pepstatin A, 100 ,ug/ml a2-macroglobulin, 50 ,ug/ml antipain), and dounced 20-25 times in a glass tissue homogenizer. The lysate was centrifuged 3 min at 500 X g, and the unlysed spheroplasts were reextracted in the same buffer. The combined supematants were centrifuged 15 min at 13 000 X g to generate a pellet (P13) and a supernatant (S13) fraction. Typically, 0.5-ml aliquots of the S13 fraction were adjusted to the following concentrations of one of several reagents: lysis buffer, 1 M NaCl, 4 M urea, or 1% Triton X-100. Extracts were incubated 10 min on ice and centrifuged 45 min at 100 000 X g.
The supernatant (S100) was removed and precipitated in 5% trichloroacetic acid, the pellet (P100) was resuspended in 100 g1 boiling buffer (50 mM Tris-HCl, pH 7.5, 1% SDS, 6 M urea, 1 mM EDTA).
The trichloroacetic acid precipitations were held on ice for 20 min and then centrifuged 2 min at 13 000 X g. The trichloroacetic acid pellets were washed twice with acetone, dried, and resuspended in 100 pl boiling buffer. The samples were then immunoprecipitated as described above.
Sucrose Gradients with Vps35p
SEY6210 wild-type spheroplasts were labeled and lysed as described above, except the chase period was for 30 min. After removing the unlysed spheroplasts (3 min at 500 x g), the lysate was centrifuged for 45 min at 100 000 X g. The pellet fraction was suspended in 2.5 ml 60% (wt/wt) sucrose, 50 mM Tris-HCl, pH 7.2, loaded on the bottom of a 5-ml ultra-clear Beckman centrifugation tube, and overlaid with 2.5 ml of 35% (wt/wt) sucrose, 50 mM Tris-HCl, pH 7.2. The gradient was centrifuged for 18 h at 170 000 X g and was harvested from top to bottom in 0.45-ml fractions. The fractions were precipitated in 5% trichloroacetic acid and immunoprecipitated with the appropriate antisera as described above.
RESULTS
Cloning of the VPS35 Gene Previously, we have described a selection procedure for the isolation of vps mutants in yeast that exploited the sorting behavior of a CPY-Inv hybrid protein (Bankaitis et al., 1986; Robinson et al., 1988) . In wild-type cells (deleted for all endogenous genes encoding invertase, Asuc), the targeting information contained in the CPY portion of the fusion protein leads to efficient sorting of the fusion protein to the vacuole (Johnson et al., 1987) . However, in vps mutant cells, the CPY-Inv hybrid protein is mislocalized and secreted from the cell. The secreted invertase activity leads to a selectable phenotype, the ability of these mutant cells to utilize sucrose, an invertase substrate, as a sole carbon source (Bankaitis et al., 1986; Robinson et al., 1988) .
To clone the wild-type VPS35 gene, we devised a simple plate overlay assay that directly tests single colonies for secretion of the CPY-Inv hybrid protein. 112 ) cells containing a CPYInv fusion (pCYI-50) (Johnson et al., 1987) were transformed with a yeast genomic library contained in a pBR322-based LEU2/CEN4/ARS1 shuttle vector. Leu+ transformants were selected on SM glucose plates supplemented with the appropriate amino acids. After 72 h, the transformants were replicated onto selective SM fructose plates and incubated for 24-36 h. The replicaplates were then overlaid with an invertase assay solution containing 1.2% agar (see MATERIALS AND METHODS). Invertase catalyzes the hydrolysis of sucrose to glucose and fructose (Goldstein and Lampen, 1975) . This activity can be easily detected by colorimetric assays designed to quantitate the release of glucose from sucrose hydrolysis (Bankaitis et al., 1986; . Because yeast cells do not transport sucrose across the plasma membrane, this enzyme assay detects only the invertase activity that has been secreted from the cells. Transformant colonies containing cells that secreted the CPY-Inv hybrid protein produced glucose and turned red after 5 min, indicating a Vps-phenotype, whereas transformants that restored normal localization of the hybrid protein to the vacuole (Vps+) remained white for >30 min (Figure 1 ).
Among 35 000 Leu+ transformants assayed for CPYInv hybrid protein secretion, 17 remained white after the overlay assay, indicating that they represented potential VPS35 gene clones. Plasmid DNA was extracted from eight of these transformants and amplified in E. coli. On retransformation, the plasmids restored intracellular localization of the CPY-Inv hybrid protein in strains carrying either of two different vps35 alleles. Restriction enzyme analysis of the complementing plasmids demonstrated that each contained largely overlapping genomic DNA inserts. A restriction map of the smallest of these inserts, a 7.5-kb complementing fragment, is shown in Figure 2A . Subcloning and complementation analysis localized the complementing activity to a 3.5-kb Nci I/Sca I fragment. The complementing Nci I/Sca I fragment (see Figure 2A ) also was subcloned into the 2,t vector pBHY10 to generate the plasmid pGPY45. Yeast transformants harboring this plasmid overproduced the VPS35 gene product .30-fold (see below). Transformation of SEY35-17 or wild-type strains with pGPY45 resulted in a Vps+ phenotype, and growth rates of the strains were unaffected, indicating that severalfold overproduction of the VPS35 gene product was not detrimental to cell growth.
To confirm that the cloned genomic fragment contained the VPS35 locus, a Nci I/Sca I fragment ( Figure  2A) Figure 2B ). An Nci I/Xba I fragment containing this deletion construct was used to transform the parental diploid strain SEY6210.5, which is homozygous for the his3-A200 mutation. Two independent His+ transformants were subjected to tetrad analysis. . Therefore, the VPS35 gene product is not required for maintaining the integrity or structure of the vacuole. Moreover, a vacuole was also observed in all newly forming buds, indicating that vacuolar inheritance/segregation is not affected in Avps35 mutants. Sorting of native CPY in the wild-type strain, the Avps35 mutant strain, and the Avps35 strain transformed with the complementing plasmid pGPY35 also was examined. Spheroplasts of the appropriate strains were labeled with Tran35S label for 5 min and chased for 60 min. The cultures were then fractionated into supernatant and pellet fractions, and CPY was immunoprecipitated. In wild-type yeast cells, >95% of the newly synthesized CPY was present as a 61-kDa mature species in an intracellular fraction (Figure 3) , indicating correct localization to the vacuole. In contrast, Avps35 spheroplasts contained <5% of the CPY as the mature species. The majority of the CPY was present as the Golgi-modified 69 kDa (p2) precursor molecule, and >90% of this p2CPY was secreted by the mutant cells (Figure 3 ). This severe sorting defect was corrected by introducing the complementing plasmid pGPY35 (CEN, VPS35) into the Avps35 mutant strain (Figure 3) .
To determine whether the protein sorting defect of Avps35 cells extended to vacuolar proteins other than CPY, we also examined the sorting of proteinase A (PrA), proteinase B (PrB), and alkaline phosphatase (ALP). As is shown in Figure 4 , -80% of the vacuolar membrane protein ALP was converted to the mature enzyme (mALP) in the Avps35 strain, consistent with proper delivery to the vacuole. Because of its retention as an integral membrane protein, no detectable levels of unprocessed precursor or mALP was found in the extracellular media fraction. A limited defect in the sorting and/or processing of ALP has also been observed with several other vps mutants, such as vpsl5 Klionsky and Emr, 1989; Herman et al., 1991) Klionsky, et al., 1988; Klionsky and Emr, 1989; Moehle, et al., 1989) . PrA (proPrA) and -80% of precursor PrB (proPrB) was converted to the mature vacuolar forms in Avps35
spheroplasts after 30 min of chase (mPrA, mPrB) ( Figure  4 ). The small portion of proPrA and proPrB found in the extracellular media was secreted from Avps35 spheroplasts at essentially the same rate as that seen for p2CPY (proCPY). In addition, the maturation kinetics Molecular Biology of the Cell l for PrA and PrB in Avps35 cells were also similar to those seen in wild-type cells. Thus, although CPY sorting was completely dependent on the VPS35 gene product, the vast majority of proPrA and proPrB was apparently properly sorted and processed in the absence of the Vps35p. These results differ somewhat from those seen in an earlier study . Far more proPrA was originally reported to be missorted in vps35 mutant cells. To rectify this discrepancy, the vacuolar protein sorting defect of the vps35 mutant cells used in the original study was compared with the sorting defect of the Avps35 cells used in this study. In all cases the extent of maturation of CPY, PrA, PrB, and ALP in cells carrying the original vps35 mutant allele was the same as in cells carrying the disrupted allele. Unlike the growth conditions used in the previous study, cells and spheroplasts used here were propagated in minimal media containing yeast extract before and after the labeling period. This helped to preserve the metabolic integrity and stability of the cells. The exclusion of yeast extract during growth and chase periods, therefore, is likely to have resulted in the exaggerated PrA maturation and sorting defect seen in the earlier study.
VPS35 Sequence Analysis
The nucleotide sequence of the VPS35 minimum complementing fragment was determined by sequencing a series of nested exonuclease III generated deletion templates by the dideoxynucleotide chain termination method. The complete nucleotide sequence of both DNA strands was determined. The DNA sequence contained one long open reading frame (ORF) of 2810 bp that has the potential to encode a protein of 937 amino acids with a predicted molecular weight of 108 344 ( Figure 5) . Upstream of the translational initiation codon, at position -50, a TATATAA element was identified that closely resembles the yeast consensus TA-TAAA sequence for transcription initiation (Struhl, 1987) . A sequence TAG . . . TAAG . . . TTT that closely approximates the proposed yeast transcriptional termination sequence according to Zaret and Sherman (1982) was found starting 89 nucleotides downstream of the ORF stop codon TAG ( Figure 5 ). Northern analysis was performed using an internal fragment of the VPS35 ORF as a probe to identify the VPS35 transcript. Consistent with the ORF size predicted from the DNA sequence, a RNA species of 3100 bases was detected ( Figure 2C) .
Analysis of the deduced protein sequence indicated that Vps35p is relatively hydrophilic and contains nine potential N-linked glycosylation sites. No obvious N-terminal signal sequence or membrane-spanning domains were detected by hydropathy analysis. A comparison of the predicted protein sequence with sequences in the Genbank, EMBL, and NBRF databases failed to detect any sequence similarities of obvious significance (Lipman and Pearson, 1985; Pearson and Lipman, 1988) . A search for sequence similarity using the 5' flanking sequence of the VPS35 gene revealed that this sequence is identical to the 3' untranslated region of the INOI gene (Dean- Johnson and Henry, 1989) . Using the TFASTA algorithm (Pearson and Lipman, 1988) , it could be shown that the sequence overlap extended to the C-terminal amino acids of the Inol protein. Because the INOI locus has previously been mapped to the left arm of chromosome X (Mortimer et al., 1989) , we conclude that the yeast VPS35 gene also maps to chromosome X.
Identification of the Vps35 Protein
To characterize the VPS35 gene product, we prepared a polyclonal antiserum against a trpE-Vps35 fusion protein. A fragment encoding 178 amino acids (amino acids 630-808 in Figure 5 ) of the VPS35 gene product was cloned into a trpE expression vector (Dieckmann and Tzagoloff, 1985) to generate an in-frame gene fusion. On induction, E. coli cells carrying this trpE-VPS35 gene fusion produced a novel protein of 55 kDa. This hybrid protein was purified and used to immunize rabbits, and the resulting antiserum was utilized in immunoprecipitation experiments to detect Vps35p. The antibodies recognized a unique polypeptide of -110 000 molecular weight from radiolabeled wildtype yeast extracts ( Figure 6, lanes 3-6) . This protein was -30-fold more abundant when the VPS35 gene was present on a multicopy plasmid ( Figure 6, lane 7) and was not detected in a Avps35 strain (GPY1 135) or by the preimmune serum ( Figure 6 , lanes 1 and 2, respectively). These data indicated that the polyclonal antiserum specifically recognized the protein product of the VPS35 gene. Pulse-chase analysis indicated the turnover rate for Vps35p is relatively slow; after a 60-min chase, there was only a slight decrease in the amount of labeled Vps35 protein present in wild-type cells ( Figure 6 , lane 5). Cells also were labeled after treatment with tunicamycin, an inhibitor of N-linked glycosylation. The size of Vps35p was unaffected by the drug, indicating that none of the nine potential sites for N-linked carbohydrate modification are utilized ( Figure 6 , lane 6) (The two minor protein species with a faster mobility than Vps35p seen after tunicamycin treatment were occasionally seen in cell extracts gen- 
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2186 CTTATTAAATCTTCGTTCATTAAAGGTGGCATCAATGTTAAATACACTTTTCCAGCAATAATCACAAATTTTTGGAAACTGATGAGGAAATGCCGTATGATACAAGAGTACCTTTTGAAA 2305 of CPY or PrA. In addition, cells overproducing Vps35p Tran35S label and gently lysed by the addition of DEAEdid not exhibit any other obvious phenotype, such as dextran under conditions that disrupt the plasma memtemperature-sensitive growth or sensitivity to osmotic brane but not internal organelles (Klionsky and Emr, stress. 1990). After this lysis, Vps35p was found to be degraded Protease protection experiments indicated that by exogenously added protease K, whereas the precurVps35p is in contact with the cytosol. In these experi-sor forms of CPY, pl and p2, residing in ER and the ments, DKY6224 (Apep4) spheroplasts were labeled with Golgi compartments, respectively (Stevens et al., 1982;  Molecular Biology of the Cell Yeast Vps35 Protein Franzusoff and Schekman, 1989) , were resistant to proteolysis. These results indicate that Vps35p is not sequestered in the lumen of an intracellular organelle. Subcellular Fractionation of the Vps35 Protein Differential centrifugation techniques were used to more precisely determine the intracellular location of Vps35p. SEY6210 spheroplasts (single copy VPS35) were radiolabeled, lysed under conditions that maintain the structural integrity of internal organelles, and the crude lysates were spun at 500 X g to remove unlysed spheroplasts. This supematant was centrifuged at 13 000 X g to generate a supematant (S13) and a pellet (P13) fraction. The S13 supematant was spun at 100 000 X g to obtain another set of supernatant (S100) and pellet (P100) fractions. The relative level of Vps35p in each fraction was assayed by immunoprecipitation ( Figure 7, A and B) . When wild-type cell lysates were examined, a small portion of Vps35p (15%) was found in the P13 pellet, but the majority of the protein (80%) was sedimented only at 100 000 X g (Figure 7, A, lanes  1-4, and B) . In contrast, a vacuolar membrane marker protein, mALP, was found predominantly in the P13 fraction ( Figure 7B ). Under comparable conditions, the P13 pellet has been shown to contain other intracellular organelles, such as nuclei (Hurt et al., 1988) and mitochondria (Goud et al., 1988; Walworth et al., 1989) . Interestingly, p2 CPY and Kex2p, which most likely reside in a late Golgi compartment (Julius et al., 1984; Graham and Emr, 1991) , are mainly found in the P100 pellet ( Figure 7B ). In addition to Golgi compartments, the P100 fraction has also been found to contain vesicular intermediates that transit between secretory pathway organelles (Walworth et al., 1989) . Thus, if Vps35p is associated with an organelle, possible candidates include transport vesicles and the Golgi apparatus but, importantly, not the vacuole.
In a similar experiment, lysates of SEY6210 cells harboring the VPS35 gene on the multicopy plasmid pGPY45 were separated into pellet and supernatant fractions at 13 000 and 100 000 X g, and the distribution of Vps35p was also determined (Figure 7 , A, lanes 5-8, and B). Unlike in the wild-type strain, the vast majority of Vps35p was found in the supernatant S100 fraction in cells overproducing this protein. harboring plasmid pGPY45 (multicopy VPS35, lanes 5-8) were labeled, osmotically lysed, clarified (500 X g), and separated into pellet (P13) and supematant (S13) fractions by centrifugation at 13 000 X g. A portion of the S13 fraction was then centrifuged at 100 000 X g to generate a second set of pellet (P100) and supematant (S100) fractions. pear to be saturated in strains that overproduce Vps35p, and the excess Vps35p remains in the 100 000 X g supernatant. The nature of the association of Vps35p with the particulate fraction P100 was investigated by treating the S13 fraction containing the Vps35p with various reagents for 10 min at 4°C: 1 M NaCl, 4 M urea, and 1% Triton X-100. The lysates were then centrifuged at 100 000 X g for 45 min, and the pellet and supernatant fractions were assayed for the presence of Vps35p by immunoprecipitation (Table 2 ). High salt concentrations and urea extracted 95 and 90% of Vps35p from the particulate fraction, respectively. These findings suggest that ionic and hydrophobic interactions may stabilize the association of Vps35p with a pelletable structure. In addition, treatment of the cell lysates with Triton X-100 also solubilized the vast majority of the particulate Vps35p, indicating that Vps35p may be associated with a cellular membrane fraction.
To further address the role of membranes in the association of Vps35p with the P100 fraction, the partitioning of Vps35p with cellular membranes was examined using sucrose density gradients. Sucrose gradients can separate organelles and membranous structures on the basis of their equilibrium density. This approach has been used successfully to localize proteins to particular compartments in the secretory pathway (Walworth et al., 1989) . We used a simple two-step sucrose gradient to establish whether Vps35p is associated with any organellar membrane. In this experiment spheroplasts generated from wild-type cells were radiolabeled and lysed. After removal of unbroken cells at 500 X g, the lysate was separated into pellet and supernatant fractions at 100 000 X g for 45 min. The pellet was resuspended in 60% sucrose and overlaid with a 35% sucrose solution. After centrifugation of the gradient at 170 000 X g for 18 h, fractions were collected and the amount of Vps35p and the vacuolar membrane marker ALP in each fraction was determined by immunoprecipitation. ALP migrated to the top of the 60% sucrose layer and into the 35% sucrose layer (Figure 8 ).
The same result was found for a membrane protein of Figure 8 . Localization of Vps35p in a two-step sucrose gradient. Labeled SEY6210 spheroplasts were lysed and spun at 500 X g to remove unbroken cells. The clarified extracts were centrifuged at 100 000 X g for 45 min and yielded a pellet and a supematant fraction. The pellet fraction was resuspended in 2.5 ml 60% sucrose, loaded on the bottom of a Beckman ultra-clear centrifuge-tube, and overlaid with 2.5 ml 35% sucrose. The sample was spun at 170 000 X g for 18 h and harvested from top (fraction 1) to bottom (fraction 11) in 0.45-ml fractions. Vps35p and alkaline phosphatase (ALP) were isolated from each gradient fraction by quantitative immunoprecipitation with the appropriate antisera.
a late Golgi compartment, Kex2p. In similar experiments membrane proteins of other organelles, such as the plasma membrane ATPase, Sec4p (a protein located on the cytoplasmic surface of secretory vesicles), and mitochondrial cytochrome c-oxidase, were shown to migrate out of the 60% sucrose solution into fractions of lesser density (Goud et al., 1988; Walworth et al., 1989 
DISCUSSION
To gain a better understanding of the role the VPS35 gene product plays in vacuolar protein sorting, the VPS35 gene was cloned, its protein product analyzed, and the phenotypic consequences of a vps35 null allele were assessed. Several VPS genes have been isolated by complementation of a temperature-sensitive growth defect associated with certain vps mutants (Banta et al., 1990; Rothman et al., 1990) . However, none of the 32 originally isolated vps35 alleles result in a temperature-conditional growth defect, so an alternative assay was devised to isolate the VPS35 gene from a yeast vacuole (Bankaitis et al., 1986; Robinson et al., 1988 Figure 4) . However, the vast majority of two other soluble proteases, PrA and PrB, are retained and matured in Avps35 mutant cells (Figure 4 ). This result indicates that CPY sorting is completely dependent on the presence of functional Vps35p. Yet, the sorting and processing of other soluble proteases (PrA and PrB) can occur in a Vps35p-independent manner. Apparently, only a subset of soluble vacuolar proteins, like CPY, may require Vps35p for their efficient sorting to the vacuole.
We provide three possible models to explain the Vps35p dependent/independent sorting of soluble vacuolar hydrolases. First, soluble vacuolar proteins could use two (or more) completely independent delivery systems. In vps35 mutant cells, the specific sorting system responsible for vacuolar delivery of CPY and presumably other unknown proteins would be inactivated, yet an independent PrA and PrB delivery system would remain intact. As a result, CPY would be secreted from the cell, whereas PrA and PrB would be delivered to the vacuole and converted to their mature forms. The presence of completely independent systems for the localization of different subsets of vacuole proteins cannot be ruled out. However, because a number of vps mutants mislocalize CPY, PrA, and PrB to the same extent Herman et al., 1991; Horazdovsky, and Emr, unpublished data) , truly independent delivery systems seem unlikely. In the second model, the active sorting of soluble vacuolar proteins may involve a single receptor complex that is required for the recognition of all soluble vacuolar proteins. This receptor complex could possess different affinities for soluble vacuolar proteins (high affinity for proPrA and proPrB but a lower affinity of proCPY), or, alternatively, different vacuolar proteins may occupy the receptor compartment for differing periods of time providing some proteins increased access to the receptor (such as proPrA and proPrB). If receptor complexes were to become limiting (in the absence of Vps35p) then proCPY, being unable to efficiently compete for receptor binding, would be secreted from the cell. This seems unlikely, however, as it has been shown previously that overexpression of PrA does not result in the missorting or secretion of CPY . If a single receptor complex with a higher affinity for PrA than for CPY is involved in the sorting pathway, the overexpression of PrA would be expected to result in the secretion of CPY. This is not the case. In addition, the near normal maturation kinetics of PrA and PrB in Avps35 cells (as well as the similar secretion rates for p2CPY and the small amount of proPrA and proPrB that are secreted in this mutant) further indicate that the delivery of PrA and PrB is largely unaffected by the loss of VPS35 gene product function and a longer residence time in the proposed sorting compartment cannot account for their vacuolar delivery. Finally, in the third model, CPY, PrA, and PrB could use the same transport system (vesicle carriers) to mediate their Golgi to vacuole delivery but may utilize different membrane receptors for their selective pack-aging into a common carrier. One receptor complex may recognize CPY, whereas a second receptor complex may recognize PrA and PrB. Though Vps35p does not resemble a receptor molecule, it may play a role in the function, modification, or packaging of the CPY-specific receptor complex. Loss of Vps35p function would inactivate the CPY-specific receptor and result in default secretion of CPY. PrA, PrB, and ALP localization would be largely unaffected in this model, as their delivery would depend on a different receptor complex(es). Present data are most consistent with this final model. Direct proof for the role of multiple receptor complexes in this protein-sorting process will require the identification of these complexes. Unfortunately, no good candidate for a receptor molecule has yet been identified among the presently characterized VPS gene products.
To learn more about the detailed biochemical function of Vps35p, we plan to assay its role in a recently developed in vitro reconstitution assay for vacuolar protein sorting , as well as identify cellular components that interact with the VPS35 gene product using both genetic and biochemical approaches.
